Supplement to the John Hancock International/Global Funds Prospectus
dated June 1, 1998
On pages 16 and 18, the "Portfolio Management" section has been changed as
follows:
John Hancock Short-Term Strategic Income Fund
Fred Cavanaugh, Jr., Arthur N. Calavritinos, CFA and Roger C. Hamilton lead the
fund's management team. Mr. Cavanaugh, senior vice president, has been in the
investment business since 1973 and joined the Adviser in 1986. Mr. Calavritinos,
vice president, has been in the investment business since 1986 and joined the
Adviser in 1988 and Mr. Hamilton, vice president, has been in the investment
business since 1980 and joined the Adviser in 1994.
John Hancock World Bond Fund
Fred Cavanaugh, Jr., James K. Ho, CFA and Anthony A. Goodchild lead the fund's
portfolio management team. Mr. Cavanaugh and Mr. Ho have been members of the
team since 1998 and Mr. Goodchild since 1994. Mr. Cavanaugh, senior vice
president, has been in the investment business since 1973 and joined the Adviser
in 1986. Mr. Ho, executive vice president, has been in the investment business
since 1977 and joined the Adviser in 1985. Mr. Goodchild, senior vice president,
has been in the investment business since 1968 and joined the Adviser in 1994.
John Hancock Global Rx Fund
The name of John Hancock Global Rx Fund has been changed to John Hancock Global
Health Sciences Fund, effective October 1, 1998. The Fund can be found in the
newspaper under the follow listings:
Global Health Sciences Class A GlHSciA
Global Health Sciences-Class B GlHSciB
September 25, 1998
GLIPS 9/98
<PAGE>
John Hancock Global Rx Fund
Supplement to the Statement of Additional Information dated March 1, 1998
The name of John Hancock Global Rx Fund has been changed to John Hancock Global
Health Sciences Fund, effective October 1, 1998.
October 1, 1998
28SAIS 10/98
